Traditional Chinese medicine research and development of secondary crisis under secrecy system 

        Too pay attention to the research and development of traditional Chinese medicine in China for a long time, Chinese traditional medicine prescription composition fluctuation kongfu, and neglect of the making craft of curative effect and quality has important influence, dosage forms, such as important elements in innovation, innovative and modern technology content is not high, so once the Chinese native medicine ingredient, is extremely easy to copy. 
 
        Is based on this, a lot of traditional Chinese medicine enterprises have their own exclusive formula, and regard it as the "lifeblood". 
 
        Once upon a time, traditional Chinese medicine industry with the protection of TCM variety made great progress. However, under the umbrella of the "secret" system, the secondary development of Chinese traditional medicine has already been in crisis: due to the special care of secrecy, the enthusiasm of research and development of the enterprise itself is not high; And there are "leaks", "secret" enterprise rarely cooperate with outside institutions. 
 
        Industry experts pointed out that for traditional Chinese medicine and traditional Chinese medicine industry development, protection of TCM variety is still very important. Published Chinese native medicine ingredient has gradually become the threshold of the TCM products to enter the international market. 
 
        According to the drug safety administration of the new rules, in addition to the yunnan baiyao, involving state secrets and technology of proprietary Chinese medicine varieties also need to open the specified components. 
 
        Last year, yunnan baiyao, tongrentang bezoar detoxify piece and bezoar daughter, the CRC is lump-sum day bolus, Hansen pharmaceutical four grinding, such as soup, proprietary Chinese medicine, by using toxic slices and some unclear and identification of medicinal materials that contained poison, have caused a lot of public opinion. 
 
        Feed in the administration of drug safety requirement toxic medicinal materials of proprietary Chinese medicine specification to add warnings, including tongrentang, guangzhou baiyun mountain, responsible for media that has completed or is to modify the instructions. 
 
        "This is our Chinese traditional medicine enterprise itself error, can't blame is misunderstanding both at home and abroad." Beijing university of Chinese medicine professor JiShaoLiang at the China association of traditional Chinese medicine (TCM) an internal conference pointed out that traditional enterprises at present the biggest problem is not the courage to own adverse reactions from the public. 
 
        For the toxic ingredients, fujian a Pan Xing TCM once said in an interview with the media, the essence of TCM and the wonders, in each taste traditional Chinese medicine "like cures like"; The viewpoints such as yunnan baiyao, after used for a long time, believe there should be a certain way to minimize the kusnezoff monkshood toxin. 
 
        Yunnan baiyao chairman secretary Wu Wei also said in an interview, yunnan baiyao in kusnezoff monkshood (system) for processed aconitum is a kind of medicinal materials, through special processing, production techniques, its toxic ingredients can be basically eliminated, (yunnan baiyao) within the scope of security. 
 
        However, truly put into negative point of yunnan baiyao, not toxic itself, but the "internal and external standards are different. 
 
        Modify the instruction before, the domestic version of yunnan baiyao never marked composition and content in the product manual. But in the United States version of yunnan baiyao prospectus, in accordance with local regulatory requirements with the composition and content. 
 
        The formula of the "national top secret", but in the United States publicly listed on the retail version. , yunnan baiyao a overseas company executive said: "this is choose to respect the local laws and spending habits, we don't offend against the principle of confidentiality".